PKO Investment Management Joint Stock Co Sells 14,805 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• PKO Investment Management cut its stake in Intuitive Surgical by 50.9% in Q4, selling 14,805 shares and holding 14,300 shares worth about $8.10 million at the period end.
• Intuitive reported strong quarterly results on April 21, beating estimates with $2.50 EPS vs. $2.08 expected and revenue of $2.77 billion (up 23% year‑over‑year).
• Analysts maintain a consensus "Moderate Buy" (18 Buys, 7 Holds, 1 Sell) with an average price target of $581.91, while the stock trades around $457.78 and carries a PE of 55.49.

PKO Investment Management Joint Stock Co decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 50.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 14,300 shares of the medical equipment provider's stock after selling 14,805 shares during the period. PKO Investment Management Joint Stock Co's holdings in Intuitive Surgical were worth $8,099,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of ISRG. Newbridge Financial Services Group Inc. boosted its stake in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $25,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth $28,000. Laurel Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth $31,000. Finally, Turning Point Benefit Group Inc. boosted its position in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of the business's stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director owned 120 shares in the company, valued at approximately $55,620. The trade was a 49.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 133 shares of the company's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 5,906 shares of company stock valued at $2,907,726. Insiders own 0.60% of the company's stock.

Intuitive Surgical Trading Up 0.0%

Shares of ISRG opened at $457.78 on Friday. The firm has a market cap of $162.13 billion, a PE ratio of 55.49, a P/E/G ratio of 3.67 and a beta of 1.51. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The stock has a fifty day moving average price of $474.86 and a 200-day moving average price of $516.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the business earned $1.81 EPS. The firm's revenue for the quarter was up 23.0% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Citigroup upgraded Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. TD Cowen dropped their price objective on Intuitive Surgical from $660.00 to $585.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group cut their target price on Intuitive Surgical from $560.00 to $515.00 and set a "hold" rating on the stock in a research note on Wednesday, April 22nd. HSBC reduced their target price on shares of Intuitive Surgical from $653.00 to $604.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. Finally, Argus decreased their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating for the company in a research report on Wednesday, February 4th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $581.91.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.